Lv11
88 积分 2026-07-20 加入
Hangzhou declaration on the global development of artificial intelligence in traditional Chinese medicine
14天前
已完结
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
27天前
已完结
高血压基层诊疗指南(2019年)
29天前
已完结
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
30天前
已完结
Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action
1个月前
已完结
Novel drug treatments for schizophrenia
1个月前
已完结
Multi-target drug discovery: An opportunity for novel and repurposed bioactive compounds
1个月前
已完结
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1
1个月前
已完结
De novo generation of multi-target compounds using deep generative chemistry
1个月前
已完结
Novel drug targets in 2025
1个月前
已完结
皖公网安备34019202002308
